Authors: Kazimierczuk, Z Gorska, A Switaj, T Lasek, W

Citation: Z. Kazimierczuk et al., Adamantylaminopyrimidines and -pyridines are potent inducers of tumor necrosis factor-alpha, BIOORG MED, 11(9), 2001, pp. 1197-1200

Authors: Feleszko, W Mlynarczuk, I Balkowiec-Iskra, EZ Czajka, A Switaj, T Stoklosa, T Giermasz, A Jakobisiak, M

Citation: W. Feleszko et al., Lovastatin potentiates antitumor activity and attenuates cardiotoxicity ofdoxorubicin in three tumor models in mice, CLIN CANC R, 6(5), 2000, pp. 2044-2052

Authors: Lasek, W Mackiewicz, A Czajka, A Switaj, T Golab, J Wiznerowicz, M Korczak-Kowalska, G Bakowiec-Iskra, EZ Gryska, K Izycki, D Jakobisiak, M

Citation: W. Lasek et al., Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice, CANC GENE T, 7(12), 2000, pp. 1581-1590

Authors: Golab, J Kozar, K Kaminski, R Czajka, A Marczak, M Switaj, T Giermasz, A Stoklosa, T Lasek, W Zagozdzon, R Mucha, K Jakobisiak, M

Citation: J. Golab et al., Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice, LIFE SCI, 66(13), 2000, pp. 1223-1230

Authors: Lasek, W Golab, J Maslinski, W Switaj, T Balkowiec, EZ Stoklosa, T Giermasz, A Malejczyk, M Jakobisiak, M

Citation: W. Lasek et al., Subtherapeutic doses of interleukin-15 augment the anti-tumor effect of interleukin-12 in a B16F10 melanoma model in mice, EUR CYTOKIN, 10(3), 1999, pp. 345-356